Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells

Despite the high prevalence of histological Benign Prostatic Hypeplasia (BPH) in elderly men, little is known regarding the molecular mechanisms and networks underlying the development and progression of the disease. Here, we explored the effects of a phytotherapeutic agent, Lipidosterolic extract o...

Full description

Bibliographic Details
Main Authors:	Stéphane Terry, Alexandre de la Taille, Aurélien Descazeaud, Francis Vacherot, Virginie Fasolo, Nanor Sirab, Grégoire Robert
Format:	Article
Language:	English
Published:	MDPI AG 2013-07-01
Series:	International Journal of Molecular Sciences
Subjects:	benign prostatic hyperplasia inflammation phytotherapy Serenoa repens gene expression analysis
Online Access:	http://www.mdpi.com/1422-0067/14/7/14301

Similar Items

Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part II
by: Stephen B. Strum
Published: (2021-08-01)

Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
by: Stephen B. Strum
Published: (2021-08-01)

Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia
by: Daniela Buonocore, et al.
Published: (2018-09-01)

<em>Serenoa repens</em> (<em>Saw palmetto</em>) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
by: Stephen B. Strum
Published: (2021-07-01)

Telogen effluvium treated with Serenoa repens supplement
by: Michele Pezza, et al.
Published: (2014-03-01)

Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study
by: Giuseppe Morgia, et al.
Published: (2013-04-01)

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
by: Leonel Fabrizio Trivisonno, et al.
Published: (2021-09-01)

Serenoa repens: Does it have any role in the management of androgenetic alopecia?
by: Murugusundram Sundaram
Published: (2009-01-01)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
by: Paolo Governa, et al.
Published: (2016-11-01)

<i>Serenoa repens</i> and <i>Urtica dioica</i> Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
by: Miriam Saponaro, et al.
Published: (2020-12-01)

Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study
by: Konstantinos Stamatiou, et al.
Published: (2013-12-01)

Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients
by: Tommaso Cai, et al.
Published: (2016-10-01)

Comparison of the Phytochemical Composition of <i>Serenoa repens</i> Extracts by a Multiplexed Metabolomic Approach
by: Guillaume Marti, et al.
Published: (2019-06-01)

Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
by: Argirović Aleksandar, et al.
Published: (2013-01-01)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
by: Antonio Alcaraz, et al.
Published: (2020-09-01)

Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil
by: Andrea Fratter, et al.
Published: (2019-02-01)

Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements
by: Brian L. Lindshield, et al.
Published: (2013-09-01)

The Clinical Impact of Hexanic Extract of <i>Serenoa repens</i> in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study
by: Michael Samarinas, et al.
Published: (2020-03-01)

Non-interventional (observational) study of application of the tamsulosin (Proflosin®) in patients with benign prostatic hyperplasia in routine clinical practice
by: L. G. Spivak, et al.
Published: (2015-02-01)

Non-interventional (observational) study of application of the tamsulosin (Proflosin®) in patients with benign prostatic hyperplasia in routine clinical practice
by: L. G. Spivak, et al.
Published: (2015-02-01)

Histomorphological effects of the oil extract of Sphenocentrum jollyanum seed on benign prostatic hyperplasia induced by exogenous testosterone and estradiol in adult Wistar rats
by: Godwin Mbaka, et al.
Published: (2019-01-01)

Saw palmetto extract: A dermatologist's perspective
by: Varshini Reddy, et al.
Published: (2017-01-01)

Evaluación de los efectos de dos extractos estandarizados de Serenoa repens, sobre la hiperplasia prostática benigna en el perro
by: García Cabrera, Renato Orlando
Published: (2015)

Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study
by: Ferdinando Fusco, et al.
Published: (2020-10-01)

PHYTOTHERAPY FOR INFLAMMATORY DISEASES OF THE PROSTATE
by: N. G. Kulchenko, et al.
Published: (2019-09-01)

An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: Results from the IDIProst® Gold Study
by: Tommaso Cai, et al.
Published: (2013-12-01)

Costs of benign prostatic hyperplasia treatment in Montenegro
by: Dabanović Vera, et al.
Published: (2015-01-01)

The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial
by: Bruno Giammusso, et al.
Published: (2017-03-01)

Minimally invasive treatments for benign prostatic hyperplasia
by: Brian A VanderBrink, et al.
Published: (2006-01-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT
by: Alexei Pleșacov, et al.
Published: (2021-05-01)

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT
by: Alexei Pleșacov, et al.
Published: (2021-05-01)

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
by: Mohamed Shaker, et al.
Published: (2016-09-01)

Combination therapy in patients with benign prostatic hyperplasia
by: Bojan Tršinar
Published: (2006-11-01)

DOES HYPOGONADISM ON RESULTS TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA?
by: A. V. Sigaev, et al.
Published: (2013-06-01)

Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
by: Ladan Dastgheib, et al.
Published: (2015-01-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia
by: Letteria Minutoli, et al.
Published: (2016-08-01)

GENERAL PRACTITIONERS’ APPROACH TO PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: Suzana Židanik
Published: (2003-07-01)

Urodynamic studies in the surgical treatment of benign prostatic hyperplasia
by: Marcelo L. de Lima, et al.
Published: (2003-10-01)